Methyl 2-cyclopentylacetate, 95.0%, 250mg

1-(4-(Trifluoromethoxy)phenyl)cyclopropane-1-carboxylic acid, 95%, 250mg

2-(2-((tert-Butyldimethylsilyl)oxy)ethoxy)ethanamine, 98%, 25g

3-Amino-1,1,1-trifluoro-4-phenylbutan-2-ol, 95+%, 250mg

TERT-BUTYL 3-NITROPIPERIDINE-1-CARBOXYLATE, 95%, 1g

2-Chloro-5-fluoropyridine, 98.0%, 25g

3-Bromo-4-chloro-5-fluorobenzonitrile, 95.0%, 250mg

[4-(1H-1,2,4-triazol-1-yl)benzyl]amine hydrochloride, 95.0%, 1g

5-Bromo-2-cyanonicotinic acid, 97.0%, 50mg

1-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-1H-PYRROLO[2,3-B]PYRIDINE, 95.0%, 5g

2,2'-Bis(2-oxazoline)>97.0%(N)5g

1,3-Bis(isocyanatomethyl)cyclohexane (cis- and trans- mixture)>99.0%(GC)500mL

Colonna capillare per GC ROTI®Cap-1701, 30 m, 0,25 mm, 0,50 µm, 1 Pezzo(i)